We found that CD44- and SOX2-positive CSCs were inhibited if we inhibited mTOR signaling, which prevents the proliferation of NPC cells and reduces secondary tumor volume and weight, but OCT4-positive CSCs were not significantly affected either in vitro or in vivo. Here, CD44 is linked to nasopharyngeal carcinoma.